Literature DB >> 11807891

Age at onset of Parkinson disease and apolipoprotein E genotypes.

Sepideh Zareparsi1, Richard Camicioli, Gary Sexton, Thomas Bird, Phillip Swanson, Jeffrey Kaye, John Nutt, Haydeh Payami.   

Abstract

Several lines of evidence suggest that the variable age at onset of Parkinson disease (PD) is likely influenced by genes. The apolipoprotein E (APOE) gene is associated with onset of Alzheimer disease, and possibly other neurodegenerative disorders. APOE has been investigated in relation to onset of PD, but results have been inconsistent. The aim of the present study was to determine if APOE genotypes are associated with onset age of PD, using a patient population large enough to assure sufficient power. We studied 521 unrelated Caucasian patients with idiopathic PD from movement disorder clinics in Oregon and Washington. Genotyping and statistical analyses were carried out using standard methods. Age at onset of PD was significantly earlier in patients with the varepsilon3varepsilon4/varepsilon4varepsilon4 genotype than in patients with the varepsilon3varepsilon3 genotype (56.1 +/- 10.9 vs. 59.6 +/- 11.0, P = 0.003). The significantly earlier onset of PD was not influenced by the possible effects of recruitment site, family history and gender. The effect of the varepsilon2varepsilon3 genotype on onset of PD differed between the two recruitment sites. There was a trend for earlier onset of PD in varepsilon2varepsilon3 patients than in varepsilon3varepsilon3 patients only in the Oregon sample. In conclusion, APOE is associated with age at onset of PD. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807891     DOI: 10.1002/ajmg.10111

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

Review 1.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

Review 2.  The two-century journey of Parkinson disease research.

Authors:  Serge Przedborski
Journal:  Nat Rev Neurosci       Date:  2017-03-17       Impact factor: 34.870

3.  APOE DNA methylation is altered in Lewy body dementia.

Authors:  Jessica Tulloch; Lesley Leong; Sunny Chen; C Dirk Keene; Steven P Millard; Andrew Shutes-David; Oscar L Lopez; Julia Kofler; Jeffrey A Kaye; Randy Woltjer; Peter T Nelson; Janna H Neltner; Gregory A Jicha; Douglas Galasko; Eliezer Masliah; James B Leverenz; Chang-En Yu; Debby Tsuang
Journal:  Alzheimers Dement       Date:  2018-03-12       Impact factor: 21.566

Review 4.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

5.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

Authors:  Faith M Harris; Walter J Brecht; Qin Xu; Ina Tesseur; Lisa Kekonius; Tony Wyss-Coray; Jo Dee Fish; Eliezer Masliah; Paul C Hopkins; Kimberly Scearce-Levie; Karl H Weisgraber; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

6.  ApoE isoform-dependent deficits in extinction of contextual fear conditioning.

Authors:  R H J Olsen; M Agam; M J Davis; J Raber
Journal:  Genes Brain Behav       Date:  2012-09-07       Impact factor: 3.449

7.  Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease.

Authors:  Haydeh Payami; Denise M Kay; Cyrus P Zabetian; Gerard D Schellenberg; Stewart A Factor; Colin C McCulloch
Journal:  Genet Epidemiol       Date:  2010-01       Impact factor: 2.135

8.  COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain.

Authors:  Michael R Hoane; Nicholas Kaufman; Michael P Vitek; Suzanne E McKenna
Journal:  J Neurotrauma       Date:  2009-01       Impact factor: 5.269

Review 9.  AR, apoE, and cognitive function.

Authors:  Jacob Raber
Journal:  Horm Behav       Date:  2008-02-26       Impact factor: 3.587

10.  Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.

Authors:  Conceição Bettencourt; Cristina Santos; Paula Coutinho; Patrizia Rizzu; João Vasconcelos; Teresa Kay; Teresa Cymbron; Mafalda Raposo; Peter Heutink; Manuela Lima
Journal:  BMC Neurol       Date:  2011-10-24       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.